Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Michael J. Koren
Based on 13 articles published since 2009
(Why 13 articles?)
||||
Expertise Level
The expertise of Michael J. Koren ranks in the
  • Top 0.14%
  • ... of 27,392 published authors worldwide on Hypercholesterolemia
  • ... from 2009 through 2019
  • ... based on contributions to 13 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Koren, Michael   ·   Koren, Michael J
Work Locations
Details
Most likely:    Miscellaneous institutions in Jacksonville      
2018
  • Department of Vascular Medicine, Academic Medical Center of Amsterdam, Amsterdam, Netherlands. · Departments of Epidemiology and Medicine, University of Iowa, Iowa City, Iowa. · Department of Medicine, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa. · Institut de recherches cliniques de Montréal, Université de Montréal, Montreal, Canada. · Department of Clinical Biochemistry, Prince Alfred Hospital, Camperdown, Australia. · Amgen Inc., Thousand Oaks, California. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Pubmed 30120772
2017
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: · CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Lipidology, Department of Medicine, University of Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK. · Amgen Inc., Thousand Oaks, California. · Amgen Ltd., Cambridge, UK. · MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: · Pubmed 28844508
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Deputy Editor, JAMA Cardiology. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Lipid Clinic, Oslo University Hospital, Oslo, Norway. · Amgen Inc, Thousand Oaks, California. · The Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg, South Africa. · Pubmed 28291870
2016
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
2015
  • Jacksonville Center For Clinical Research, Jacksonville, FL (M.J.K.). · The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH (D.K.). · Alexion, Cheshire, CT (R.P.). · LabCorp, Raleigh, NC (D.W.). · Regeneron Pharmaceuticals, Inc, Tarrytown, NY (P.B., S.H.). · Sanofi, Paris, France (C.H.). · Virginia Commonwealth University and National Clinical Research, Richmond, VA (J.M.M.K.). · Pubmed 26586732
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
  • Jacksonville Center for Clinical Research , Jacksonville, FL , USA. · Pubmed 25609019
2014
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. Electronic address: · Center for Clinical and Basic Research, Ballerup, Denmark. · Bethesda Health Research Center, Bethesda, Maryland. · Orange County Research Center, Tustin, California. · Amgen Inc., Thousand Oaks, California. · L-MARC Research Center, Louisville, Kentucky. · Pubmed 24691094
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2012
Possible:    Virginia Commonwealth University   Contact    
2012
  • Virginia Commonwealth University and National Clinical Research, Inc., Richmond, USA. · Pubmed 22463922
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by Michael J. Koren about Hypercholesterolemia:

  • Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies. 2018
  • Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. 2017
  • Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. 2017
  • Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study. 2017
  • Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. 2016
  • Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy. 2015
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. 2015
  • Safety and efficacy of alirocumab 150 mg every 2 weeks, a fully human proprotein convertase subtilisin/kexin type 9 monoclonal antibody: A Phase II pooled analysis. 2015
  • Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab. 2014
Show List of Full Article Records
Google Searches

Learn more about Michael J. Koren using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Jacksonville
Virginia Commonwealth University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Jacksonville
2018
  • Department of Vascular Medicine, Academic Medical Center of Amsterdam, Amsterdam, Netherlands. · Departments of Epidemiology and Medicine, University of Iowa, Iowa City, Iowa. · Department of Medicine, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa. · Institut de recherches cliniques de Montréal, Université de Montréal, Montreal, Canada. · Department of Clinical Biochemistry, Prince Alfred Hospital, Camperdown, Australia. · Amgen Inc., Thousand Oaks, California. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Pubmed 30120772
2017
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: · CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Lipidology, Department of Medicine, University of Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK. · Amgen Inc., Thousand Oaks, California. · Amgen Ltd., Cambridge, UK. · MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: · Pubmed 28844508
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Deputy Editor, JAMA Cardiology. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Lipid Clinic, Oslo University Hospital, Oslo, Norway. · Amgen Inc, Thousand Oaks, California. · The Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg, South Africa. · Pubmed 28291870
2016
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
2015
  • Jacksonville Center For Clinical Research, Jacksonville, FL (M.J.K.). · The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH (D.K.). · Alexion, Cheshire, CT (R.P.). · LabCorp, Raleigh, NC (D.W.). · Regeneron Pharmaceuticals, Inc, Tarrytown, NY (P.B., S.H.). · Sanofi, Paris, France (C.H.). · Virginia Commonwealth University and National Clinical Research, Richmond, VA (J.M.M.K.). · Pubmed 26586732
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
  • Jacksonville Center for Clinical Research , Jacksonville, FL , USA. · Pubmed 25609019
2014
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. Electronic address: · Center for Clinical and Basic Research, Ballerup, Denmark. · Bethesda Health Research Center, Bethesda, Maryland. · Orange County Research Center, Tustin, California. · Amgen Inc., Thousand Oaks, California. · L-MARC Research Center, Louisville, Kentucky. · Pubmed 24691094
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2012
Virginia Commonwealth University
2012
  • Virginia Commonwealth University and National Clinical Research, Inc., Richmond, USA. · Pubmed 22463922
Yearly article counts 01314202000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.